Correction from recent highs is continuing. Where the bottom? Sold out high and will get back in, though DY and PE are out of whack. Looking at sub $1.40 as possible re entry.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025